Zevalin European approval delayed

Idec (IDPH) said European approval for its Zevalin non-Hodgkin's lymphoma (NHL) radioimmunotherapy has been delayed due to compliance

Read the full 182 word article

How to gain access

Continue reading with a
two-week free trial.